Intermittent Portal and Graft Purge in Living Donor Liver Transplantation
NCT ID: NCT02845154
Last Updated: 2017-03-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
80 participants
INTERVENTIONAL
2015-10-31
2017-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Purge Vs no Purge in Living Donor Liver Transplantation Recipients
NCT02540447
Remote Ischemic Preconditioning in Liver Transplantation
NCT02534025
Impact Of Timing Of Drainage Of Massive Ascites On Operative And Post-Operative Course In Living-Donor Liver Transplant Recipients. A Prospective Randomized Controlled Trial.
NCT02867293
Liver Protection of RIPC in Pediatric Living Donor Liver Transplantation
NCT02830841
Effect of Mannitol on Postreperfusion Syndrome During Living Donor Liver Transplant
NCT05277623
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control (bolus purge)
The portal vein clamp will be totally released after end of portal vein anastomosis and all graft and portal blood contents are allowed free and complete access to the systemic circulation via the inferior vena cave
bolus purge
complete and uninterrupted purge
Intermittent Purge
The portal clamp will be released in situ for 5 seconds to allow purge of the graft and portal contents into the systemic circulation, followed by 30 seconds of portal clamping again. This will be followed by another two cycles of 5 seconds declamping and 30 seconds clamping , then, the portal clamp will be completely released.
Intermittent purge
intermittent portal purge
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
bolus purge
complete and uninterrupted purge
Intermittent purge
intermittent portal purge
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mansoura University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amr Mohamed Yassen
Professor of Anesthesia and Intensive Care
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amr M Yassen, MD
Role: STUDY_DIRECTOR
Mansoura Faculty of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Liver transplantation program - Gastroenterology surgical center
Al Mansurah, Dakahlia Governorate, Egypt
Liver transplantation project - Gastroenterology surgical center - Mansoura university
Al Mansurah, Dakahlia Governorate, Egypt
Gastroenterology surgical center - Mansoura university
Al Mansurah, Dakahlia Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LDLDPURGE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.